TABLE 3.
Correlation and linear regression analysis of prothrombin time (PT), activated partial thromboplastin (APTT), hemoclot thrombin inhibitor (HTI) with drug concentration measured by HPLC-MS in healthy subjects.
Methods | Correlation analysis | Linear regression analysis | ||||||
|
|
|||||||
Time | 2 h | 8 h | 12 h | 2 h | 8 h | 12 h | ||
APTT | r | 0.80** | 0.40** | 0.36** | Beta | 0.24 | –0.04 | –0.02 |
p | 5.41E–28 | 0.90E–4 | 7.90E-5 | t | 2.40 | –0.61 | –0.22 | |
p | 0.02* | 0.55 | 0.82 | |||||
PT | r | 0.38** | 0.21* | 0.13 | Beta | –0.08 | 0.12 | 0.03 |
p | 1.90E–5 | 0.03 | 0.16 | t | –1.16 | 1.92 | 0.51 | |
p | 0.25 | 0.06 | 0.61 | |||||
HTI | r | 0.94** | 0.84** | 0.80** | Beta | 0.49 | 0.64 | 0.77 |
p | 5.97E–55 | 3.97E–32 | 1.48E–27 | t | 4.57 | 7.70 | 9.84 | |
p | 0.20E–3** | 7.64E–12** | 9.13E–17** |
HTI, hemoclot thrombin inhibitor; APTT, activated partial thromboplastin; PT, prothrombin time; **Correlation is significant at the 0.01 level (2-tailed); *Correlation is significant at the 0.05 level (2-tailed). r means correlation coefficient.